KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2016)

Historic Interest & Investment Income for CRISPR Therapeutics AG (CRSP) over the last 2 years, with Q4 2016 value amounting to $1000.0.

  • CRISPR Therapeutics AG's Interest & Investment Income rose 10101.01% to $1000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was -$8.0 million, marking a year-over-year change of. This contributed to the annual value of -$8.0 million for FY2016, which is 735370.37% down from last year.
  • Per CRISPR Therapeutics AG's latest filing, its Interest & Investment Income stood at $1000.0 for Q4 2016, which was up 10101.01% from -$1000.0 recorded in Q3 2016.
  • In the past 5 years, CRISPR Therapeutics AG's Interest & Investment Income ranged from a high of $1000.0 in Q4 2016 and a low of -$8.0 million during Q1 2016